Personalis, Inc.

Personalis Inc. (PSNL) has shown zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating stable operational footing on those dimensions. However, low signal in a short window doesn't mean low risk—the genomics and precision medicine space carries specific structural vulnerabilities that require deeper analysis. The full $49 Report extends the timeline to 12 months, calculates dilution risk scores from equity issuance patterns, maps financing history and burn rates, and flags AI-related regulatory exposure signals relevant to PSNL's clinical sequencing operations. The full $49 Report adds quantified shareholder dilution risk, 12-month event history context, and sector-specific AI/regulatory risk signals.